Market Overview:
The global anticancer drug market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of cancer, technological advancements in anticancer drugs, and rising demand for targeted therapies and combination therapies. The global anticancer drug market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into targeted drugs, cytotoxic drugs, hormonal drugs, and others. The targeted drugs segment is expected to grow at a CAGR of 8% from 2018 to 2030 due to increasing adoption of these drugs owing to their better efficacy and safety profile as compared with traditional chemotherapy regimens. On the basis of application, the market is divided into immunotherapy, targeted therapy chemotherapy hormonal therapy,, and others).
Product Definition:
An anticancer drug is a type of medication that is used to treat cancer. The primary purpose of anticancer drugs is to kill cancer cells, which helps to slow or stop the progression of the disease.
Targeted Drugs:
Targeted drugs are those medications which act on a specific body part or tissue to cure the disease. These drugs have a higher success rate as compared to conventional ones and also cause fewer side effects. The major factor that propels the growth of targeted anticancer drug market includes better efficacy in comparison with non-specific therapies, rising awareness about targeted therapy among patients & physicians, increasing demand for precision medicine, and favorable reimbursement policies by government organizations such as Medicare & Medicaid.
Cytotoxic Drugs:
Cytotoxic drugs are the ones that damage or destroy the cells in a living organism. The most common way of doing this is by affecting cell division, which leads to apoptosis (programmed cell death). Other ways of cytotoxic drug action include interference with DNA replication, gene expression, and cellular signaling pathways.
The anticancer drug market is one of the fastest growing markets globally due to increasing cancer cases and awareness about early diagnosis.
Application Insights:
The market is segmented by application into immunotherapy, targeted therapy, chemotherapy and hormonal therapy. The immunotherapy segment dominated the overall market in terms of revenue share in 2017. This can be attributed to the rising incidence of cancer and increasing usage of anticancer drugs that are used for treatment purposes.
Immunotherapy is a type of medicine that targets and helps to fight against cancerous cells by stimulating the immune system to seek out & attack them. This approach has been proved effective against various types of cancers including lung, breast, colorectal as well as skin cancers. Some major companies offering products under this category are Bristol-Myers Squibb Company LLC., Pfizer Inc., Novartis AG., Eli Lilly & Company LLY -0.5%, Astrazeneca AZN -0.* And Merck KGaA MRK 1%.
Regional Analysis:
North America dominated the global market in 2017. Key factors contributing to its growth include a rise in the prevalence of cancer, availability of effective treatment methods, and presence of key players investing heavily in R&D. Moreover, increasing government funding for cancer research is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and growing awareness about early diagnosis & treatment methods for various cancers such as immunotherapy and targeted therapy. Furthermore, an increase in investment by governments & private companies coupled with high potentiality areas such as China & India are some other factors driving this regional market during the forecast period.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for anticancer drug market. According to World Health Organization (WHO), the number of new cases of cancer is expected to increase by 70% over next two decades. This will create huge demand for anticancer drugs and boost the growth of anticancer drug market.
- Rising awareness about cancer: There is growing awareness among people about different types of cancers and their symptoms, which is propelling the demand for anticancer drugs. Moreover, governments are also investing in campaigns to raise awareness about early detection and treatment options for various types of cancers, which will further fuel the growth ofanticancer drug market in coming years.
- Technological advancements in anticancer drugs: The technological advancements in development and productionofanticcancer drugs are providing impetus tothegrowthoftheanticancerdrugmarket .Forinstance, targeted therapies such as monoclonal antibodies are becoming increasingly popular due their ability tomimic natural processes within cellsandthusofferbettertreatment outcomes than traditional chemotherapy regimens .Thisislikelytoresultinthedemandfortargetedtherapiesincreasinginthefuture ,drivingthegrowthoftheanticancergrowthdriver4). 4) Increasing prevalenceof lifestyle-relatedcancers: There has been a significant rise in lifestyle-related cancers such as lungcancer,breastcancerandsoloncarcinomaoverthepastfewyears .Thisisthereasonwhy there has
Scope Of The Report
Report Attributes
Report Details
Report Title
Anticancer Drug Market Research Report
By Type
Targeted Drugs, Cytotoxic Drugs, Hormonal Drugs, Others
By Application
Immunotherapy, Targeted Therapy, Chemotherapy, Hormonal Therapy, Others
By Companies
Roche, Celgene, Pfizer, Bristol-Myers Squibb, Novartis, AstraZeneca, Teva Pharmaceuticals, Bayer, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Anticancer Drug Market Report Segments:
The global Anticancer Drug market is segmented on the basis of:
Types
Targeted Drugs, Cytotoxic Drugs, Hormonal Drugs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immunotherapy, Targeted Therapy, Chemotherapy, Hormonal Therapy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Celgene
- Pfizer
- Bristol-Myers Squibb
- Novartis
- AstraZeneca
- Teva Pharmaceuticals
- Bayer
- GlaxoSmithKline
Highlights of The Anticancer Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Targeted Drugs
- Cytotoxic Drugs
- Hormonal Drugs
- Others
- By Application:
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Hormonal Therapy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anticancer Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anticancer drug is a type of medication that is used to treat cancer. Anticancer drugs can help to slow the growth of cancer cells and may also make it more difficult for them to spread.
Some of the major players in the anticancer drug market are Roche, Celgene, Pfizer, Bristol-Myers Squibb, Novartis, AstraZeneca, Teva Pharmaceuticals, Bayer, GlaxoSmithKline.
The anticancer drug market is expected to register a CAGR of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anticancer Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anticancer Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anticancer Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anticancer Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anticancer Drug Market Size & Forecast, 2018-2028
4.5.1 Anticancer Drug Market Size and Y-o-Y Growth
4.5.2 Anticancer Drug Market Absolute $ Opportunity
Chapter 5 Global Anticancer Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anticancer Drug Market Size Forecast by Type
5.2.1 Targeted Drugs
5.2.2 Cytotoxic Drugs
5.2.3 Hormonal Drugs
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anticancer Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anticancer Drug Market Size Forecast by Applications
6.2.1 Immunotherapy
6.2.2 Targeted Therapy
6.2.3 Chemotherapy
6.2.4 Hormonal Therapy
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anticancer Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anticancer Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anticancer Drug Analysis and Forecast
9.1 Introduction
9.2 North America Anticancer Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anticancer Drug Market Size Forecast by Type
9.6.1 Targeted Drugs
9.6.2 Cytotoxic Drugs
9.6.3 Hormonal Drugs
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anticancer Drug Market Size Forecast by Applications
9.10.1 Immunotherapy
9.10.2 Targeted Therapy
9.10.3 Chemotherapy
9.10.4 Hormonal Therapy
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anticancer Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Anticancer Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anticancer Drug Market Size Forecast by Type
10.6.1 Targeted Drugs
10.6.2 Cytotoxic Drugs
10.6.3 Hormonal Drugs
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anticancer Drug Market Size Forecast by Applications
10.10.1 Immunotherapy
10.10.2 Targeted Therapy
10.10.3 Chemotherapy
10.10.4 Hormonal Therapy
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anticancer Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anticancer Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anticancer Drug Market Size Forecast by Type
11.6.1 Targeted Drugs
11.6.2 Cytotoxic Drugs
11.6.3 Hormonal Drugs
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anticancer Drug Market Size Forecast by Applications
11.10.1 Immunotherapy
11.10.2 Targeted Therapy
11.10.3 Chemotherapy
11.10.4 Hormonal Therapy
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anticancer Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Anticancer Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anticancer Drug Market Size Forecast by Type
12.6.1 Targeted Drugs
12.6.2 Cytotoxic Drugs
12.6.3 Hormonal Drugs
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anticancer Drug Market Size Forecast by Applications
12.10.1 Immunotherapy
12.10.2 Targeted Therapy
12.10.3 Chemotherapy
12.10.4 Hormonal Therapy
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anticancer Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anticancer Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anticancer Drug Market Size Forecast by Type
13.6.1 Targeted Drugs
13.6.2 Cytotoxic Drugs
13.6.3 Hormonal Drugs
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anticancer Drug Market Size Forecast by Applications
13.10.1 Immunotherapy
13.10.2 Targeted Therapy
13.10.3 Chemotherapy
13.10.4 Hormonal Therapy
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anticancer Drug Market: Competitive Dashboard
14.2 Global Anticancer Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Celgene
14.3.3 Pfizer
14.3.4 Bristol-Myers Squibb
14.3.5 Novartis
14.3.6 AstraZeneca
14.3.7 Teva Pharmaceuticals
14.3.8 Bayer
14.3.9 GlaxoSmithKline
